SCHEMBL31004910

SCHEMBL31004910

C[C@@H]1O[C@@H](O[C@H]2[C@@H](Oc3c(-c4ccc(O)cc4)oc4cc(O)cc(O)c4c3=O)O[C@H](CO)[C@H](O)[C@@H]2O[C@@H]2O[C@@H](C)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O

nearest known ligand 0.88

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HB P07237 7/20 0.88
▸ GAA P10253 6/20 0.83
▸ POLB P06746 5/20 0.83
▸ KDM4E B2RXH2 5/20 0.83
▸ APEX1 P27695 3/20 0.83
▸ RECQL P46063 2/20 0.83
▸ L3MBTL1 Q9Y468 2/20 0.78
▸ ALPL P05186 2/20 0.78
▸ ALPI P09923 2/20 0.78
▸ ALPG P10696 1/20 0.78
▸ AKR1B1 P15121 3/20 0.77
▸ CA12 O43570 2/20 0.77
▸ CA2 P00918 2/20 0.77
▸ CA4 P22748 2/20 0.77
▸ CA7 P43166 2/20 0.77
▸ ACHE P22303 1/20 0.77
▸ NQO2 P16083 1/20 0.76
▸ XDH P47989 2/20 0.73
▸ MAPT P10636 3/20 0.72
▸ CYP3A4 P08684 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29208522 0.99 P4HB (0.87) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL29504121 0.96 GAA (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL30870428 0.96 GAA (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL30870432 0.96 GAA (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL26679507 0.96 GAA (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL30637484 0.96 GAA (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL38650627 0.96 GAA (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL30662209 0.95 P4HB (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL30916855 0.95 P4HB (0.91) P4HBGAAPOLBKDM4EAPEX1
SCHEMBL1819742 0.95 P4HB (0.91) P4HBGAAPOLBKDM4EAPEX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) 2025-11-06 — — US disclosed
CN-118452324-A A fish feed additive containing fucoidan and other Chinese herbal medicinal components 自然资源部第三海洋研究所 2024-08-09 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM S100A8, TP53, AQP1 P4HB 1151/4885GAA 805/4885POLB 1095/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback